2021 PAD Fall Symposium
The Hershey Lodge
Hershey, PA
September 23-25
Hershey, PA
September 23-25
PAD is excited to be back in person for our Fall Symposium! Join us for a smaller education meeting featuring great speakers and a variety of topics.
Featured topics:
Social Events
We also have several social events planned so that we can reconnect.
Attendee registration is now open! Use the link below to view the agenda and register. We hope you'll join us at the Fall Symposium this September!
Featured topics:
- Modern Management of Hidradenitis Suppurativa
- Diagnosis of Melanocytic Lesions with Clinical-Pathology Correlations
- Psoriasis
- What's New in the Diagnosis & Treatment of Hair Loss Disorders
- Key Tips for Managing Pigmentation Issues in Skin of Color Patients
- Advancing Care for People Living with Moderate to Severe Atopic Dermatitis
- Fillers
- and more!
Social Events
We also have several social events planned so that we can reconnect.
- Welcome Reception - Thursday, September 23
- Resident Reception - Friday, September 24
Attendee registration is now open! Use the link below to view the agenda and register. We hope you'll join us at the Fall Symposium this September!
2020 Annual Scientific Meeting Recap
In November 2020, The Pennsylvania Academy of Dermatology and Dermatologic Surgery held a virtual series of educational sessions. The series included exceptional presentations from experts in the field, including:
Our educational sessions were enhanced by Virtual Grand Rounds. Thank you to all of institutions that provided our Virtual Grand Rounds: Penn State University, University of Pittsburgh, University of Pennsylvania, Geisinger Medical Center, Cooper University Hospital, and Philadelphia College of Osteopathic Medicine.
Finally, a big thank you to our sponsors and exhibitors who supported our Annual Meeting. You can still visit our virtual exhibit hub by clicking here.
- Arash Mostaghimi, MD - Brigham and Women's Hospital/Harvard Medical School
- Amy McMichael, MD - Wake Forest
- Misha Rosenbach, MD - University of Pennsylvania
- Kanade Shinkai, MD - University of California, San Francisco
- Lisa Albany, JD - American Academy of Dermatology
- Laura Ferris, MD - University of Pittsburgh
Our educational sessions were enhanced by Virtual Grand Rounds. Thank you to all of institutions that provided our Virtual Grand Rounds: Penn State University, University of Pittsburgh, University of Pennsylvania, Geisinger Medical Center, Cooper University Hospital, and Philadelphia College of Osteopathic Medicine.
Finally, a big thank you to our sponsors and exhibitors who supported our Annual Meeting. You can still visit our virtual exhibit hub by clicking here.
Information/Questions?
Please contact:
Pennsylvania Academy of Dermatology and Dermatologic Surgery
400 Winding Creek Blvd.
Mechanicsburg, PA 17050
Toll-free: (866) 650-3376 • Email: info@padermatology.org
Please contact:
Pennsylvania Academy of Dermatology and Dermatologic Surgery
400 Winding Creek Blvd.
Mechanicsburg, PA 17050
Toll-free: (866) 650-3376 • Email: info@padermatology.org
External Events
PAD members are receiving this complimentary On-Demand CME Webcourse as a benefit of their PAD membership. This program was originally offered as a webinar in May 2021.
Pustular Psoriasis: Recognizing And Treating A Rare But Serious Disease
Course Type: On-Demand Webcourse
Number of Credits: 1
Credit Type: CME/MOC
Course Type: On-Demand Webcourse
Number of Credits: 1
Credit Type: CME/MOC
Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.
Current systemic treatment has involved cyclosporine, methotrexate or acitretin. The Japanese Dermatological Association has also published guidelines that include a treatment algorithm. However, it has been recognized that IL-36 cytokines are likely the key driver of the autoimmune response in pustular psoriasis. There are two novel, investigational monoclonal antibodies that target the IL-36 receptor. In addition, agents that target other molecules have also been investigated.
Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease will review the most recent guidelines for diagnosing, classifying, and assessing the severity of pustular psoriasis and provide information on current treatment guidelines and agents in development to manage this rare group of disorders.
FACULTY
Alice B. Gottlieb, MD, PhD
Clinical Professor of Dermatology,
Department of Dermatology
Division of Rheumatology
Icahn School of Medicine at Mount Sinai
Medical Director, Department of Dermatology
Mount Sinai at Union Square
New York, NY
Abby S. Van Voorhees, MD
Professor and Chair,
Department of Dermatology
Eastern Virginia Medical School
Norfolk, VA
PROVIDER
Jointly provided by the Potomac Center for Medical Education and Rockpointe
In collaboration with the National Psoriasis Foundation
SUPPORTER
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Thank you for choosing Rockpointe for your CME activities.
We appreciate your participation in our programs.
Current systemic treatment has involved cyclosporine, methotrexate or acitretin. The Japanese Dermatological Association has also published guidelines that include a treatment algorithm. However, it has been recognized that IL-36 cytokines are likely the key driver of the autoimmune response in pustular psoriasis. There are two novel, investigational monoclonal antibodies that target the IL-36 receptor. In addition, agents that target other molecules have also been investigated.
Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease will review the most recent guidelines for diagnosing, classifying, and assessing the severity of pustular psoriasis and provide information on current treatment guidelines and agents in development to manage this rare group of disorders.
FACULTY
Alice B. Gottlieb, MD, PhD
Clinical Professor of Dermatology,
Department of Dermatology
Division of Rheumatology
Icahn School of Medicine at Mount Sinai
Medical Director, Department of Dermatology
Mount Sinai at Union Square
New York, NY
Abby S. Van Voorhees, MD
Professor and Chair,
Department of Dermatology
Eastern Virginia Medical School
Norfolk, VA
PROVIDER
Jointly provided by the Potomac Center for Medical Education and Rockpointe
In collaboration with the National Psoriasis Foundation
SUPPORTER
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Thank you for choosing Rockpointe for your CME activities.
We appreciate your participation in our programs.
